Clinical trial
Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's…
NCT00294554 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00294554 |
|---|---|
| Title | Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia |
| Official title | Double-Blind Placebo-Controlled Trial of Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Cognitive Impairment, Dementia |
| Intervention type | Drug |
| Interventions | Memantine, Placebo Oral Tablet |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 22, 2006 |
| Last update posted | Sep 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: